Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026)
Lensar (LNSR) reported Depreciation & Amortization (CF) of $904000.0 for Q1 2026, up 7.11% year-over-year from $844000.0 in Q1 2025, and down 4.24% on a QoQ basis from $944000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $904000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 7.11% year-over-year to $904000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 15.29% YoY) and the FY2025 annual result came in at $3.6 million, up 20.94% from the prior year.
- Depreciation & Amortization (CF) slipped to $904000.0 in Q1 2026 per LNSR's latest filing, from $944000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $944000.0 in Q4 2025 and bottomed at $541000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $651000.0 (2023), against an average of $713058.8.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) jumped 66.37%; it then grew 1.93% in 2023.
- Tracing LNSR's Depreciation & Amortization (CF) over 5 years: stood at $577000.0 in 2022, then rose by 12.82% to $651000.0 in 2023, then surged by 34.25% to $874000.0 in 2024, then climbed by 8.01% to $944000.0 in 2025, then decreased by 4.24% to $904000.0 in 2026.
- Per Business Quant, the three latest LNSR Depreciation & Amortization (CF) figures stand at $904000.0 (Q1 2026), $944000.0 (Q4 2025), and $928000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 904,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 904,000.00 |
| Mar 31, 2026 | 904,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Jun 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 666,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Dec 31, 2023 | 651,000.00 |
| Dec 31, 2023 | 651,000.00 |
| Sep 30, 2023 | 609,000.00 |
| Sep 30, 2023 | 609,000.00 |
| Jun 30, 2023 | 580,000.00 |
| Jun 30, 2023 | 580,000.00 |
| Mar 31, 2023 | 578,000.00 |
| Mar 31, 2023 | 578,000.00 |
| Dec 31, 2022 | 577,000.00 |
| Dec 31, 2022 | 577,000.00 |
| Sep 30, 2022 | 571,000.00 |
| Sep 30, 2022 | 571,000.00 |
| Jun 30, 2022 | 569,000.00 |
| Jun 30, 2022 | 569,000.00 |
| Mar 31, 2022 | 541,000.00 |
| Mar 31, 2022 | 541,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Sep 30, 2021 | 393,000.00 |
| Sep 30, 2021 | 393,000.00 |
| Jun 30, 2021 | 342,000.00 |
| Jun 30, 2021 | 342,000.00 |
| Mar 31, 2021 | 328,000.00 |
| Mar 31, 2021 | 328,000.00 |
| Dec 31, 2020 | 274,000.00 |
| Dec 31, 2020 | 274,000.00 |
| Sep 30, 2020 | 227,000.00 |
| Sep 30, 2020 | 227,000.00 |
| Jun 30, 2020 | 331,000.00 |
| Jun 30, 2020 | 331,000.00 |
| Mar 31, 2020 | 477,000.00 |
| Mar 31, 2020 | 477,000.00 |
| Dec 31, 2019 | 548,000.00 |
| Dec 31, 2019 | 548,000.00 |